Press Releases

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Dec. 5, 2008) - WebTech Wireless Inc. (TSX: WEW), a leading provider of location-based and fleet Telematics services, is pleased to announce it has scheduled a conference call to present its first quarter financial results on Thursday, December 11, 2008, at 5:00 pm Eastern Time (2:00 pm Pacific Time).

Anwar Sukkarie, President and Chief Executive Officer, and Scott B. Edmonds, Chief Financial Officer, will discuss the Company's financial results and performance for the Quarter ended October 31, 2008. The results are scheduled for release after the close of market on December 11, 2008.

Interested parties may participate in the call by dialing 1-800-734-4208 or (212) 231-2900 (for international callers). The conference call will be archived on the Company's website at: www.webtechwireless.com.

About WebTech Wireless Inc.

WebTech Wireless Inc. (TSX: WEW) is a global Telematics, location-based services provider that develops, manufactures, and delivers turnkey wireless solutions designed to improve productivity and profitability. WebTech Wireless products include wireless hardware and software services running on cellular and satellite networks, and include Automatic Vehicle Location, Mapping, Reporting, Vehicle Diagnostics, Driver Status, In-vehicle Telemetry, Messaging, In-vehicle Navigation, and wireless application and Internet connectivity. WebTech Wireless is currently providing devices and services worldwide in eight languages to over forty-one countries covering five continents. WebTech Wireless' scalable solutions are used by a broad range of small, medium and Fortune 500 companies and by governments. For more information, please visit www.webtechwireless.com.

Forward Looking Statements

This press release contains forward-looking statements involving risks and uncertainties pertaining to, but not limited to product plans, timing, content, and pricing of products, market and industry expectations, the wireless communications industry, the mobile fleet industry, and general economic and political conditions. Given the risks and uncertainties inherent in the markets and industries referred to in this press release, WebTech Wireless cannot guarantee that any forward looking statements will be realized.

Trademarks are the property of their owners.

The Toronto Stock Exchange does not accept responsibility for the adequacy or accuracy of this release.

FOR FURTHER INFORMATION PLEASE CONTACT:
        WebTech Wireless Inc.
        Eric Wilson
        Press / Media Contact
        (778) 370-9609
        Email: press@webtechwireless.com

        WebTech Wireless Inc.
        R. Joe Dhami
        Investor Relations Contact
        1-877-811-4518 ext. 462
        Email: ir@webtechwireless.com
        Website: www.webtechwireless.com

Source: WebTech Wireless Inc.

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Dec. 5, 2008) - Candente Resource Corp. (TSX: DNT)(BVL: DNT)(WKN:GW4) ("Candente" or the "Company") announces that Mark Katsumata has resigned as Chief Financial Officer to pursue other interests and that, effective November 21, 2008, Ms. Aurora Davidson has assumed the role of Chief Financial Officer.

Ms. Davidson holds a Certified General Accountant designation from the Certified General Accountants Association of British Columbia and a BSc in Business Administration from Alliant International University in San Diego, California. She has over 18 years of experience in financial and general business management assisting private and public companies in the roles of Chief Financial Officer, Vice-president, Finance and Corporate Controller within the mining and high technology sectors.

Since 2003, Ms. Davidson has focused on providing part-time CFO services predominantly to companies in the mining sector, including Amerigo Resources Ltd.

"We at Candente wish Mr. Katsumata every success in his future endeavors and express our gratitude for his contributions to the Company since he joined us in October, 2007," stated Ms. Joanne Freeze, President and CEO.

About Candente Resource Corp.

Candente is a diversified exploration company with copper, gold, silver, and zinc projects in Peru and Mexico. Candente's directors and management have a track record in the discovery and development of copper, gold and silver deposits and subscribe to principles, which ensure that exploration and development activities are beneficial to the local communities.

This news release may contain forward-looking statements including but not limited to comments regarding the timing and content of upcoming work programs, geological interpretations, receipt of property titles, potential mineral recovery processes, etc. Forward-looking statements address future events and conditions and therefore involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements. Candente relies upon litigation protection for forward-looking statements.

NR253

FOR FURTHER INFORMATION PLEASE CONTACT:
        Candente Resource Corp.
        Joanne C. Freeze
        President and CEO
        (604) 689-1957
        Email: jfreeze@candente.com
        Website: www.candente.com

Source: Candente Resource Corp.

FREMONT, Calif.--(BUSINESS WIRE)-- The Logitech(R) G9 Laser Mouse has always offered gamers the ability to tune their mouse for the way they play - including features such as weight tuning, interchangeable grips and custom-color LEDs. Now, Logitech (SIX: LOGN) (NASDAQ: LOGI) lets you make the G9 mouse even more personal with the introduction of the Logitech(R) G9 Laser Mouse ID Grip. With the ID Grip, you can have the image of your choice printed on the palm area of the grip. You can choose among game-specific artwork, a selection from a gallery of designs created by Logitech, or an image you provide.

"In surveying gamers who own a Logitech mouse, we learned that more than 65 percent want to mod their hardware," said Rory Dooley, Logitech senior vice president and general manager of the Control Devices business unit. "The Logitech G9 Laser Mouse ID Grip provides gamers with a new level of personalization. Whether it's a guild logo or a personal photo, we're delighted to give gamers the ability to make the G9 mouse even more a reflection of their unique personality."

To provide a durable image that won't fade even after intense gaming, the rub- and fade-proof image is applied with a specially designed custom printing process that infuses it into the surface of the grip. The result is a high-quality, high-resolution color image. And adding an image to the grip is easy. You can choose from game-specific artwork, such as Command & Conquer(TM) Red Alert(TM) 3 from Electronic Arts Inc., or upload a personal image of your own. (Certain restrictions apply; uploads subject to technical and image-content requirements.)

In addition to helping you further personalize your G9 mouse, Logitech's grip presents a new shape. Providing exceptional palm and wrist support, the broad-shaped grip is designed for extended gameplay, and can make even those gamers with large hands feel comfortable. In addition, a soft-touch side grip offers a comfortable texture that feels good during short gaming sessions and epic battles. Easy to snap on to the G9 Laser Mouse, the ID Grip can be attached or detached with the push of a button.

Pricing and Availability

Available only in the U.S., the Logitech G9 Laser Mouse ID Grip is available to order online at www.logitech.com/IDGrip beginning today for a suggested retail price of $19.99 (U.S.).

About Logitech

Logitech is a world leader in personal peripherals, driving innovation in PC navigation, Internet communications, digital music, home-entertainment control, gaming and wireless devices. Founded in 1981, Logitech International is a Swiss public company listed on the SIX Swiss Exchange (LOGN) and on the Nasdaq Global Select Market (LOGI).

Logitech, the Logitech logo, and other Logitech marks are registered in Switzerland and other countries. All other trademarks are the property of their respective owners. For more information about Logitech and its products, visit the company's Web site at www.logitech.com.

(LOGI - IR)

    Source: Logitech

Bank of America Survey Finds Despite Tightening Their Wallets, Americans Are Further from Achieving Their Retirement Goals Amidst Weakening Economy

A growing number of Americans are concerned that the current economic crisis is threatening to leave them further behind on their retirement plans, according to a new survey released by Bank of America. The 2008 Bank of America Retirement Savings Survey, which reflects the mindset and behavior of approximately one thousand people across the country, finds that six in ten Americans are spending less than they were three months ago as a result of the current economic climate. However, even with this decreased spending, more than half of the general public and 40 percent of affluent Americans are also saving less than they were three months ago -- with approximately one in five citing that they're saving "much less."

    Full story at:
http://media.prnewswire.com/en/jsp/main.jsp?resourceid=3878286

'Dark Knight' Fans Want Johnny Depp, Angelina Jolie in Next Batman Movie, Says Blockbuster Survey

As the December 9 DVD release of "The Dark Knight" approaches, fans have casting picks for director Christopher Nolan should he create another Batman film. According to a survey conducted by Blockbuster Inc., movie fans are hoping to see Johnny Depp and Angelina Jolie play starring roles. The villains that fans would most like to see Batman take on are The Riddler and The Joker's therapist turned girlfriend Harley Quinn.

    Full story at:
http://media.prnewswire.com/en/jsp/main.jsp?resourceid=3878086

CBGB Rocks Again

The iconic and legendary NYC Rock Club, CBGB known for launching the careers of Television, Ramones, Blondie, Patti Smith, the B-52's, and the Talking Heads, is making a comeback under a new ownership team headed by James Blueweiss and Robert Williams, partners in the newly formed CBGB Holdings based in New York City. The new team includes members of founder Hilly Kristal's immediate family, long-time employees, and music industry advisors that have a history with the club. Next summer, CBGB will hit the road with the Vans WARPED Tour as an interactive traveling exhibit with integrated media, mobile, and internet linkages.

    Full story at:
http://media.prnewswire.com/en/jsp/main.jsp?resourceid=3878467

Kristin Chenoweth Soars to the Top on Billboard's Chart With New Holiday CD A Lovely Way To Spend Christmas

Sony Masterworks is pleased to announce that Kristin Chenoweth's recently released holiday recording, A Lovely Way To Spend Christmas, has garnered the highest sales and chart ranking in her recording career. With increased sales of 63 percent this week, A Lovely Way To Spend Christmas holds the number one position on Billboard's Heat Seekers -- Top New Artist Chart and continues to steadily climb Billboard's Seasonal and Top 200 Charts.

    Full story at:
http://media.prnewswire.com/en/jsp/main.jsp?resourceid=3878189

The PR Newswire Broadcast Minute is available by email at no charge to members of the media who sign up for PR Newswire for Journalists, http://www.prnewswire.com/media . For more information, contact Rob Fisher at 408-365-8793 or email rob.fisher@prnewswire.com

SOURCE PR Newswire

AUSTIN, Texas--(BUSINESS WIRE)-- Asuragen, Inc. announced today that the Signature(R) LTx v2.0 Leukemia Translocation Panel was released as a "Conformite Europeenne" or "European Conformity" CE IVD product under the European Directive on In Vitro Diagnostic Medical Devices. The CE-marked Signature(R) LTx v2.0 is a qualitative in vitro diagnostic device for use in a clinical laboratory to identify specific fusion transcripts in total RNA from whole blood or bone marrow to aid in the clinical diagnosis of translocation positive leukemias. Clinical validation studies showed 100% diagnostic accuracy (95% confidence interval 93.8 to 100%) in comparison to standard cytogenetic methods. This represents the world's first Luminex-based molecular oncology IVD product.

The assay is a multiplex reverse transcription PCR (RT-PCR) amplification, followed by multiplex amplicon detection on the Luminex(R) 100(TM) IS or 200(TM) system. The liquid bead array assay format provides comprehensive information on 12 different fusion transcripts associated with ALL, AML, APL or CML and an internal control in a single test. "Standard cytogenetic analysis by karyotyping or fluorescence in situ hybridization can be laborious or require multiple successive hybridizations to detect a given chromosomal translocation. Asuragen's expertise in multiplex RNA-based assays enables the rapid molecular diagnosis of leukemia fusion transcripts and therefore improves workflow and efficiency in the clinical laboratory while nicely complementing standard diagnostic hematopathology testing," according to Rollie Carlson, Ph.D., President, Asuragen Inc.

The Signature(R) LTx platform was initially launched in early 2005 as a research use only (RUO) product in order to assess its potential utility in the clinical diagnostic environment. After extensive clinical evaluation at major academic medical institutions, Signature(R) LTx v2.0 CE IVD is now available immediately to clinical laboratories throughout the European Union. "This launch signifies the transformation of an established research product into a clinical assay that provides fast and accurate results needed to aid in leukemia diagnosis and subsequent therapeutic decision making. It illustrates the potential of Asuragen's broad menu of leukemia research tools and represents another step towards Asuragen's goal of providing cutting edge clinical products to the global market," said Matt Winkler, Ph.D., Chief Scientific Officer and Chief Executive Officer, Asuragen, Inc.

The Signature(R) LTx v2.0 CE IVD assay follows the European launch of RNARetain(TM), Asuragen's clinically validated and cGMP manufactured sample collection and RNA stabilization in vitro diagnostic device.

About Asuragen, Inc.

Asuragen is a fully integrated diagnostic reagent company and molecular biology service provider, focused on molecular oncology and genetic diseases, with emphasis on microRNA (miRNA). Asuragen's current diagnostic product portfolio consists of Signature(R) Genetic Testing and Oncology Testing products as well as industry leading controls and standards engineered using its patented Armored RNA(R) technology. Asuragen is empowered with a high level of scientific expertise and assay development along with a well developed business infrastructure, cGLP testing services and an established cGMP manufacturing facility that allows it to span the spectrum of discovery, testing, production and commercialization. Asuragen is dedicated to developing new technologies that will become cutting edge clinical products. More information is available at the Company's website: www.asuragen.com.

In addition, Asuragen has a miRNA therapeutics program which was recently spun off into a separate entity called Mirna Therapeutics. More information on Mirna Therapeutics is available at www.mirnatherapeutics.com.

    Source: Asuragen, Inc.